Clinical Trial Update: Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab [NA]

View source ↗

Summary

A clinical trial update assessing the antibody response to the Hepatitis B vaccine in older lymphoma patients undergoing rituximab therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Lymphoma

Drugs mentioned

• Hepatitis B vaccine (Hepatitis B vaccine)
• Rituximab (rituximab)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Lymphoma | NA | Status: UNKNOWN